HemaSphere
(Jun 2022)
S120: ACUTE MYELOID LEUKEMIA REPRESENTS A FERROPTOSIS-SENSITIVE CANCER ENTITY RAISING THE POSSIBILITY FOR NOVEL TARGETING STRATEGIES
- A. Narr,
- H. Alborzinia,
- E. Donato,
- F. Vogel,
- T. Boch,
- A.-M. Leppä,
- A. Waclawiczek,
- S. Renders,
- A. Schulze,
- A. Trumpp
Affiliations
- A. Narr
- 1 Division of Stem Cells & Cancer, German Cancer Research Center (DKFZ)
- H. Alborzinia
- 1 Division of Stem Cells & Cancer, German Cancer Research Center (DKFZ)
- E. Donato
- 1 Division of Stem Cells & Cancer, German Cancer Research Center (DKFZ)
- F. Vogel
- 4 Division of Tumor Metabolismus und Microenvironment, German Cancer Research Center (DKFZ), Heidelberg, Germany
- T. Boch
- 1 Division of Stem Cells & Cancer, German Cancer Research Center (DKFZ)
- A.-M. Leppä
- 1 Division of Stem Cells & Cancer, German Cancer Research Center (DKFZ)
- A. Waclawiczek
- 1 Division of Stem Cells & Cancer, German Cancer Research Center (DKFZ)
- S. Renders
- 1 Division of Stem Cells & Cancer, German Cancer Research Center (DKFZ)
- A. Schulze
- 4 Division of Tumor Metabolismus und Microenvironment, German Cancer Research Center (DKFZ), Heidelberg, Germany
- A. Trumpp
- 1 Division of Stem Cells & Cancer, German Cancer Research Center (DKFZ)
- DOI
-
https://doi.org/10.1097/01.HS9.0000843372.29380.06
- Journal volume & issue
-
Vol. 6
pp.
21
– 22
WeChat QR code